NCT07020065
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07020065
Title Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Swiss Cancer Institute (Responsible Party)
Indications
Therapies
Age Groups: senior
Covered Countries CHE

Facility Status City State Zip Country Details
HFR Fribourg Fribourg Villars-sur-Glâne 1752 Switzerland Details
Kantonsspital Aarau Aarau CH-5001 Switzerland Details
Kantonsspital Baden Baden 5404 Switzerland Details
Universitätsspital Basel Basel 4031 Switzerland Details
Inselspital Bern 3010 Switzerland Details
Kantonsspital Baselland Bruderholz 4101 Switzerland Details
Kantonsspital Graubuenden Chur CH-7000 Switzerland Details
Spital Thurgau AG - Kantonsspital Frauenfeld Frauenfeld 8501 Switzerland Details
Hôpitaux Universitaires de Genève Geneva 1211 Switzerland Details
Kantonsspital Olten - Solothurner Spitäler Olten 4600 Switzerland Details
Kantonsspital - St. Gallen Sankt Gallen CH-9007 Switzerland Details
Hôpital du Valais - Sion Sion 1951 Switzerland Details
EOC Istituto Oncologico della Svizzera Italiana (IOSI) Viganello 6962 Switzerland Details
Kantonsspital Winterthur Winterthur 8401 Switzerland Details
KSW Kantonsspital Winterthur Winterthur 8401 Switzerland Details
Stadtspital Zürich Triemli Zurich 8063 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field